Search results
19 June 2026 - 2 mins read
Balancing benefit and risk: Nisha Vora on the science of pharmacovigilance
“My job is to be a guardian of patient safety.”As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly....
11 March 2026 - 2 mins read
A Life in Science: Shaping early development with patient focus
New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how...
04 March 2026 - 2 mins read
Moving NET Science Forward Together at ENETS 2026
An article by Dr Marius Tham, Director Global Medical Affairs, Ipsen ...
03 March 2026 - 2 mins read
From idea to impact: accelerating the promise of early science
By Christelle Huguet, EVP & Head of R&D, Ipsen...
15 May 2026 - 1 min read
Right medicine, right person: Jacintha Sivarajah on science with purpose
“All medicines have side effects, but it's just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah ...
05 December 2025 - 2 mins read
Bold Science, Bold Ambition: Shaping the Future of Oncology at Ipsen
Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D at Ipsen, shares his vision for building a balanced and sustainable pipeline powered by bold science....
13 March 2026 - 2 mins read
From culture to clinic: Alison Mason on making science work at scale
“We’re doing real science. For real people. And we’re doing it together. That’s what matters most to me.” – Alison Mason ...
04 March 2026 - 2 mins read
Faire progresser la science ensemble à l’ENETS 2026
Un article par le Dr Marius Tham, Directeur Affaires Médicales Globales, Ipsen...
12 January 2026 - 2 mins read
Bridging science and leadership: Elisabetta Leo on guiding early development at Ipsen
“I felt, during my career path, that I was more a scientist rather than a leader; in my current role, I’m bridging the two as a research leader.” ...
10 September 2026 - 2 mins read
Why evidence matters: Seema Meloni on making data meaningful
“In order to help all partners understand the value of a medicine, we provide the wrap-around support of data coming out of clinical trials.” ...